Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Enterprise value to sales ratio
3Y CAGR
-21.3%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 9.74 | -24.3% |
| 2024 | 12.86 | +168.6% |
| 2023 | 4.79 | -76.0% |
| 2022 | 19.98 | - |
| 2021 | 0.00 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |